Back to Search Start Over

Glenmark announces presentation of New Subtype Analysis of GBR 830

Source :
BioSpectrum (India). March 4, 2019
Publication Year :
2019

Abstract

The Phase 2a study was conducted to investigate the safety of GBR 830 Glenmark Pharmaceuticals has announced the presentation of a new post hoc analysis of data from a Phase [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
BioSpectrum (India)
Publication Type :
News
Accession number :
edsgcl.576869074